Phase I/II study of transarterial marker placement for particle beam therapy for hepatocellular carcinoma

Phase I/II study of transarterial marker placement for particle beam therapy for hepatocellular carcinoma - Phase I/II study of transarterial marker placement for particle beam therapy for hepatocellular carcinoma

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024108

Enrollment

Registered

2016-09-20

Start date

2016-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Pre-particle therapy transcatheter marker placement

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Indication for particle therapy Informed consent

Exclusion criteria

Exclusion criteria: Allergic reaction to contrast agent

Design outcomes

Primary

Measure	Time frame
The distance between the markers and the edge of GTV	—

Secondary

Measure	Time frame
1. The technical success rate of transarterial marker placement 2. The completion rate of particle therapy using marker 3. The safety of transarterial marker placement	—

Countries

Japan

Contacts

Public ContactKazuki Terashima

Hyogo Ion Beam Medical Center Department of Radiology

k.terashima@kmyr.jp0791580100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026